Non-mandatory guidance for employers concerning opioid overdose reversal medication

(a) In general Not later than 270 days after the date of enactment of this Act, the Secretary of Labor, acting through the Occupational Safety and Health Administration, shall issue nonmandatory guidance to employers on— (1) acquiring and maintaining opioid overdose reversal medication; and (2) offering voluntary training to employees on an annual basis on the usage of such medication. (b) Employer defined In this section, the term employer has the meaning given such term in section 3 of the Occupational Safety and Health Act of 1970 (29 U.S.C. 652), except that such term does not include the United States Postal Service.